China Neurodegenerative Disease Market (2025-2031) | Segmentation, Analysis, Competitive Landscape, Outlook, Industry, Companies, Share, Size & Revenue, Forecast, Trends, Value, Growth

Name: China Neurodegenerative Disease Market (2025-2031) | Segmentation & Analysis
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor Antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Other Drug Types) And Competitive Landscape

Product Code: ETC6748485	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

China Neurodegenerative Disease Market Outlook
Market Size of China Neurodegenerative Disease Market, 2024
Forecast of China Neurodegenerative Disease Market, 2031
Historical Data and Forecast of China Neurodegenerative Disease Revenues & Volume for the Period 2021- 2031
China Neurodegenerative Disease Market Trend Evolution
China Neurodegenerative Disease Market Drivers and Challenges
China Neurodegenerative Disease Price Trends
China Neurodegenerative Disease Porter's Five Forces
China Neurodegenerative Disease Industry Life Cycle
Historical Data and Forecast of China Neurodegenerative Disease Market Revenues & Volume By Indication Type for the Period 2021- 2031
Historical Data and Forecast of China Neurodegenerative Disease Market Revenues & Volume By Parkinson's Disease for the Period 2021- 2031
Historical Data and Forecast of China Neurodegenerative Disease Market Revenues & Volume By Alzheimer's Disease for the Period 2021- 2031
Historical Data and Forecast of China Neurodegenerative Disease Market Revenues & Volume By Multiple Sclerosis for the Period 2021- 2031
Historical Data and Forecast of China Neurodegenerative Disease Market Revenues & Volume By Huntington Disease for the Period 2021- 2031
Historical Data and Forecast of China Neurodegenerative Disease Market Revenues & Volume By Other Indication Types for the Period 2021- 2031
Historical Data and Forecast of China Neurodegenerative Disease Market Revenues & Volume By Drug Type for the Period 2021- 2031
Historical Data and Forecast of China Neurodegenerative Disease Market Revenues & Volume By N-methyl-D-aspartate Receptor Antagonists for the Period 2021- 2031
Historical Data and Forecast of China Neurodegenerative Disease Market Revenues & Volume By Cholinesterase Inhibitors for the Period 2021- 2031
Historical Data and Forecast of China Neurodegenerative Disease Market Revenues & Volume By Dopamine Agonists for the Period 2021- 2031
Historical Data and Forecast of China Neurodegenerative Disease Market Revenues & Volume By Immunomodulatory Drugs for the Period 2021- 2031
Historical Data and Forecast of China Neurodegenerative Disease Market Revenues & Volume By Other Drug Types for the Period 2021- 2031
China Neurodegenerative Disease Import Export Trade Statistics
Market Opportunity Assessment By Indication Type
Market Opportunity Assessment By Drug Type
China Neurodegenerative Disease Top Companies Market Share
China Neurodegenerative Disease Competitive Benchmarking By Technical and Operational Parameters
China Neurodegenerative Disease Company Profiles
China Neurodegenerative Disease Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 China Neurodegenerative Disease Market Overview

3.1 China Country Macro Economic Indicators

3.2 China Neurodegenerative Disease Market Revenues & Volume, 2021 & 2031F

3.3 China Neurodegenerative Disease Market - Industry Life Cycle

3.4 China Neurodegenerative Disease Market - Porter's Five Forces

3.5 China Neurodegenerative Disease Market Revenues & Volume Share, By Indication Type, 2021 & 2031F

3.6 China Neurodegenerative Disease Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

4 China Neurodegenerative Disease Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing aging population in China leading to increased prevalence of neurodegenerative diseases

4.2.2 Increasing awareness and diagnosis of neurodegenerative diseases in China

4.2.3 Technological advancements in healthcare leading to better treatment options for neurodegenerative diseases

4.3 Market Restraints

4.3.1 High cost of treatment and medication for neurodegenerative diseases

4.3.2 Limited access to specialized healthcare facilities in rural areas of China

4.3.3 Stringent regulatory approvals for new treatment options in the neurodegenerative disease market

5 China Neurodegenerative Disease Market Trends

6 China Neurodegenerative Disease Market, By Types

6.1 China Neurodegenerative Disease Market, By Indication Type

6.1.1 Overview and Analysis

6.1.2 China Neurodegenerative Disease Market Revenues & Volume, By Indication Type, 2021- 2031F

6.1.3 China Neurodegenerative Disease Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F

6.1.4 China Neurodegenerative Disease Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F

6.1.5 China Neurodegenerative Disease Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F

6.1.6 China Neurodegenerative Disease Market Revenues & Volume, By Huntington Disease, 2021- 2031F

6.1.7 China Neurodegenerative Disease Market Revenues & Volume, By Other Indication Types, 2021- 2031F

6.2 China Neurodegenerative Disease Market, By Drug Type

6.2.1 Overview and Analysis

6.2.2 China Neurodegenerative Disease Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F

6.2.3 China Neurodegenerative Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F

6.2.4 China Neurodegenerative Disease Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F

6.2.5 China Neurodegenerative Disease Market Revenues & Volume, By Immunomodulatory Drugs, 2021- 2031F

6.2.6 China Neurodegenerative Disease Market Revenues & Volume, By Other Drug Types, 2021- 2031F

7 China Neurodegenerative Disease Market Import-Export Trade Statistics

7.1 China Neurodegenerative Disease Market Export to Major Countries

7.2 China Neurodegenerative Disease Market Imports from Major Countries

8 China Neurodegenerative Disease Market Key Performance Indicators

8.1 Number of clinical trials for new neurodegenerative disease treatments in China

8.2 Adoption rate of telemedicine services for neurodegenerative disease management

8.3 Investment in research and development for innovative therapies for neurodegenerative diseases

8.4 Number of healthcare professionals specializing in neurodegenerative diseases in China

9 China Neurodegenerative Disease Market - Opportunity Assessment

9.1 China Neurodegenerative Disease Market Opportunity Assessment, By Indication Type, 2021 & 2031F

9.2 China Neurodegenerative Disease Market Opportunity Assessment, By Drug Type, 2021 & 2031F

10 China Neurodegenerative Disease Market - Competitive Landscape

10.1 China Neurodegenerative Disease Market Revenue Share, By Companies, 2024

10.2 China Neurodegenerative Disease Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Neurodegenerative Disease Market

Global Neurodegenerative Disease Market

Middle East Neurodegenerative Disease Market

North America Neurodegenerative Disease Market

Russia Neurodegenerative Disease Market

Saudi Arabia Neurodegenerative Disease Market

Singapore Neurodegenerative Disease Market

Slovakia Neurodegenerative Disease Market

South Korea Neurodegenerative Disease Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here